The Cancer Institute NSW

What The Cancer Institute NSW does

Cancer Institute NSW is a statutory body established in 2003 under the Cancer Institute (NSW) Act 2003, operating as NSW's designated cancer control agency within the NSW Health system. The organization is wholly government-owned and funded through NSW Government appropriations, with no commercial shareholders. Its mandate is to reduce the impact of cancer across NSW across the full continuum of care — prevention, early detection, diagnosis, treatment, and survivorship — and it is described as the largest funder of cancer research in the state.

The agency operates a multi-platform portfolio built around statutory data infrastructure and population-scale service delivery. Core technology assets include the NSW Cancer Registry (collecting mandatory notifications under the Public Health Act 2010), the Cancer Notification Portal, the Clinical Trials Portal (statewide enrolment tracking and funding allocation across Local Health Districts), the Prostate Cancer Outcomes Registry – NSW, the Hereditary Cancer Registry, the CanDLe linked-data research program, and the BreastScreen NSW screening database. Sub-brands include eviQ (peer-reviewed cancer treatment protocols), eviQ Education (CPD-certified learning for cancer-care staff), Canrefer (specialist finder), iCanQuit (smoking cessation), BreastScreen NSW (free mammography via fixed and mobile units), and the Pave smartphone app (vaping cessation with Google/Apple SSO).

Business model is government appropriations-based, not commercial: services are provided at no direct cost to patients (screening, smoking cessation, cancer information). Revenue streams consist of NSW Government funding channelled through the Ministry of Health. Customer segments are institutional (NSW Local Health Districts, hospitals, pathology laboratories, researchers, universities) and population-wide (patients, carers, multicultural and Aboriginal communities, rural and remote residents). The agency's competitive position rests on its statutory monopoly over cancer control functions, its comprehensive statewide data assets, and its deep integration into the NSW public health system. Strategic programs include the NSW Cancer Plan, the NSW Aboriginal Cancer Strategy, Reporting for Better Cancer Outcomes (RBCO), and the Patient-reported Measures (PRMs) Program; the agency also administers the annual NSW Premier's Awards for Outstanding Cancer Research (now in its 21st year).

Name

The Cancer Institute NSW

Legal name

Cancer Institute NSW

Website

https://cancer.nsw.gov.au

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

51–100 employees

Short description

The Cancer Institute NSW is NSW's statutory cancer control agency, established under the 2003 Act, funding cancer research, operating statewide screening programs, maintaining cancer registries, and delivering prevention and patient-support services across New South Wales.

Ownership category

akta.pro rank

Product category

Public Health Cancer Control Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Health Services (8000)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

• Cancer control services
• Public health programs
• Cancer screening
• Cancer registry data
• Cancer research grants

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Government Funding: Publicly funded NSW Government agency established under Cancer Institute NSW (2003) Act. Receives government appropriations to operate cancer control programs, screening services, and research grants.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

The Cancer Institute NSW operates as NSW's designated cancer control agency, coordinating statewide cancer prevention, screening, diagnosis, treatment, and survivorship programs. It runs the NSW Cancer Registry and clinical registries, funds cancer research through competitive grants and fellowships, delivers evidence-based treatment protocols via eviQ, and provides public-facing programs including BreastScreen NSW mammography screening and smoking/vaping cessation support through iCanQuit and the Pave App.

Product overview

The Cancer Institute NSW operates a multi-platform portfolio centred on its main website (cancer.nsw.gov.au), which serves as the comprehensive gateway to all programs. Key platforms include eviQ (cancer treatment protocols) and eviQ Education (CPD-certified learning for cancer care staff); Canrefer (specialist finder for multidisciplinary cancer teams); iCanQuit (smoking and vaping cessation); BreastScreen NSW (breast cancer screening); and the Pave App (vaping quit support with Google/Apple login). The organisation maintains major data infrastructure including the Cancer Institute NSW Clinical Trials Portal (for statewide clinical trial enrolment reporting), Cancer Notification Portal (for mandatory case submissions), the NSW Cancer Registry, Prostate Cancer Outcomes Registry – NSW, Hereditary Cancer Registry, CanDLe (linked data research program), and BreastScreen NSW Data. Strategic programs include the NSW Cancer Plan, NSW Aboriginal Cancer Strategy, Reporting for Better Cancer Outcomes (RBCO), Patient-reported Measures (PRMs), and the annual NSW Premier's Awards for Outstanding Cancer Research. A diverse grants program supports community engagement, research equipment, fellowships, translational research, and clinical trials capacity across NSW.

Differentiator

Problem solved

Functional benefit

Brands

• eviQ: Cancer treatments protocols platform providing evidence-based cancer treatment protocols and information for healthcare professionals
• eviQ Education
• Canrefer
• iCanQuit
• BreastScreen NSW
• Pave

Products and services

• Cancer Institute NSW Website Central NSW Government website providing comprehensive cancer information, prevention guidance, screening details, patient support resources, and gateway to all Cancer Institute NSW programs. For patients, the public, health professionals, and researchers in NSW.
• eviQ Evidence-based, peer-reviewed cancer treatment protocols platform used by health professionals across Australia. For medical, nursing, and allied health practitioners delivering cancer care.
• eviQ Education Online learning platform offering educational resources and continuing professional development hours for medical, nursing, allied health, and general ward staff in cancer care.
• Canrefer Referral tool enabling patients and GPs to find cancer specialists and multidisciplinary cancer care teams across NSW and the ACT.
• iCanQuit Smoking and vaping cessation support platform providing resources and guidance to help people quit smoking and understand the damaging effects of vaping.
• BreastScreen NSW Free breast cancer screening program offering mammograms for the early detection of breast cancer, targeting women in NSW through fixed and mobile screening units.
• Pave App Smartphone application that helps users quit vaping by collecting age, postcode, and quitting data to provide personalised support, with third-party login via Google or Apple.
• Cancer Institute NSW Clinical Trials Portal Statewide portal for reporting and tracking cancer clinical trial enrolments across NSW Local Health Districts, specialty networks, and private institutions, supporting data collection, statewide reporting, and funding allocation.
• Cancer Statistics NSW Public dashboard providing cancer incidence, mortality, screening, and clinical trial enrolment data for NSW, available to researchers, health professionals, and the public.
• Cancer Notification Portal Secure online portal enabling pathology laboratories, hospitals, and treatment centres to submit mandatory cancer case notifications to the NSW Cancer Registry under the Public Health Act 2010.
• NSW Cancer Registry Statutory registry collecting notifications of all new cancer cases and cancer deaths in NSW, used for planning, treatment, and research to improve cancer outcomes.
• Hereditary Cancer Registry Clinical registry tracking hereditary cancer cases, supporting family cancer service clinicians in assessing cancer risk for patients and their families.
• Prostate Cancer Outcomes Registry – NSW (PCOR-NSW) Clinical quality registry monitoring prostate cancer care, treatment outcomes, and complications to guide best clinical practices across NSW, operating as part of the national Prostate Cancer Outcomes Registry Australia and New Zealand.
• CanDLe Program Linked data program allowing researchers to request access to linked cancer-related datasets for approved research projects, governed by the Five Safes framework.
• NSW Cancer Plan Strategic plan guiding cancer control in NSW, covering overriding principles, priority areas, system enablers, and performance monitoring for the state's cancer control efforts.
• NSW Aboriginal Cancer Strategy Dedicated strategy addressing cancer outcomes for Aboriginal people in NSW, covering the continuum of care, capability enhancement, and service delivery improvements.
• Research Equipment Grant Competitive grant scheme funding research equipment to accelerate cancer research and improve outcomes for people across NSW.
• Research Fellowships Fellowship grants supporting early and mid-career researchers in NSW to strengthen and expand cancer research that can shape the future of cancer care.
• Translational Program Grants Grants supporting translational research programs that translate laboratory and clinical findings into improved patient care and cancer outcomes.
• Aboriginal Community-Led Cancer Research Grant Community grant scheme supporting Aboriginal community-led research into cancer control, with published opening and closing dates for applicants.
• Cervical Screening Community Engagement Grants Grants funding community engagement activities to increase awareness and participation in cervical screening among underserved populations.
• Cancer Quality Improvement Collaboration Grant Grant funding quality improvement collaborations across cancer services to drive systemic improvements in cancer care outcomes.
• Reporting for Better Cancer Outcomes (RBCO) Continuous improvement program providing participating institutions with confidential performance reports on cancer care metrics, including clinical trial enrolments, to support quality improvement.
• Patient-reported Measures (PRMs) Program Program collecting patient-reported outcome and experience measures to monitor and improve the quality of cancer care across NSW health services.

Quantifiable outcome

• Breast screening bookings increased by 22% (12,000 additional women screened)
• +1 more outcomes

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Partnerships

Five partnerships are on record, tiered core and supporting.

• NSW Agency for Clinical InnovationcoreStrategic or Co-development PartnerPartnership established to operate the Prostate Cancer Outcomes Registry - NSW (PCOR-NSW), working together to guide best clinical practices and improve quality of patient care.
• NSW Local Health DistrictscoreStrategic or Co-development PartnerClinical trial units across NSW Local Health Districts participate in the Cancer Institute NSW Clinical Trials Program, receiving funding based on trial enrolments to improve patient access to cancer clinical trials.
• NSW Healthcare Interpreter ServicessupportingStrategic or Co-development PartnerCollaborative engagement with healthcare interpreters to increase clinical trial enrolments from culturally and linguistically diverse communities, with Western Sydney LHD achieving four-fold increase in interpreter bookings.
• NSW Universities and Research InstitutionscoreStrategic or Co-development PartnerApplications sought from NSW-based universities, cancer services, hospitals, and Local Health Districts for competitive grant funding to support innovative community and research projects aligned to the NSW Cancer Plan.
• NSW Ministry of HealthcoreOthersGoverned by NSW Health policies and Privacy Management Plan. Reports performance to NSW Ministry of Health and Australian Institute of Health and Welfare.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Cancer Australia: Australia's national cancer control agency, established by the Australian Government to coordinate and provide national leadership in cancer control. Most direct functional counterpart to CINSW with overlapping responsibilities across screening, research funding, data, and clinical guidance.
• Cancer Council NSW: NSW's leading cancer charity, focused on cancer prevention, research funding, advocacy, and patient support within the same NSW catchment. Overlaps heavily with CINSW on screening promotion, research grants, and public health campaigns targeting the same residents.
• Canadian Partnership Against Cancer: Canada's national cancer control partnership funded by Health Canada to coordinate cancer strategy, screening, research translation, and performance reporting. Direct international equivalent of CINSW's whole-of-system cancer-control mandate.

Broad incumbents

• National Cancer Institute (NCI): The US federal cancer research and control agency. Operates a much larger national-scale mandate covering research funding, clinical trials infrastructure, and population-level cancer data, providing a broad-incumbent analogue to CINSW's mission.
• Cancer Research UK: The world's largest charitable funder of cancer research, with comparable programs in research funding, public health campaigns, and patient information. A larger-scale incumbent operating across the UK rather than a single jurisdiction.
• NHS England Cancer Programme: The cancer-care program within NHS England responsible for cancer screening, treatment standards, and outcomes monitoring. Comparable in coordinating population-scale cancer services and reporting, but embedded in a much larger national health system.

Regional players

• Cancer Council Victoria: Victoria's state-based cancer charity and research funder. Performs similar functions to Cancer Council NSW within a different Australian state, providing a regional peer perspective on cancer control in another jurisdiction.
• Victorian Cancer Registry: Victoria's statutory population-based cancer registry collecting incidence and mortality data. Direct registry-level peer to the NSW Cancer Registry, operating in an adjacent Australian state with comparable notification and reporting workflows.

Others

• Movember Foundation: Global men's health charity that co-funds the Prostate Cancer Outcomes Registry with CINSW. Functions as both a partner and an adjacent funder with overlapping priorities in prostate cancer outcomes and translational men's health research.
• National Comprehensive Cancer Network (NCCN): US-based alliance of leading cancer centres that publishes authoritative clinical practice guidelines in oncology. Conceptually aligned with eviQ's evidence-based treatment-protocol function and similarly consumed by cancer clinicians nationally.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/cancernsw
• Facebookfacebook.com/cancerinstitutensw
• LinkedInlinkedin.com/company/cancer-institute-nsw

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Cancer Institute NSW